OPTIVE FUSION

Swiss trademark · 644946 · Word mark · In force

Register entry

Registration number
644946
Application number
56368/2013
Status
In force
Type
Word mark
Filed
May 31, 2013
Registered
Jun 10, 2013
Published
Jun 10, 2013
Protected until
May 31, 2033
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Ophthalmika, einschliesslich Augentropfen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 24, 2024

    Agent’s address changed

    Representative
    Baker McKenzie Zurich, Holbeinstrasse 30, 8034 Zürich → Baker McKenzie Switzerland AG, Holbeinstrasse 30, 8034 Zürich

    Published in Swissreg on 24.01.2024

  2. Feb 24, 2023

    Renewed

    Published in Swissreg on 24.02.2023

  3. Oct 11, 2022

    Agent removed

    Representative
    A.W. Metz & Co. AG, Kreuzbühlstrasse 8, 8008 Zürich (removed)

    Published in Swissreg on 11.10.2022

  4. Oct 11, 2022

    Agent entered

    Owner
    Allergan, Inc., 2525 Dupont Drive, Irvine, CA 92612, USA → Allergan, Inc., 2525 Dupont Drive, Irvine, CA 92612, USA, Allergan, Inc., 2525 Dupont Drive, Irvine (CA 92715), USA
    Representative
    Baker McKenzie Zurich, Holbeinstrasse 30, 8034 Zürich

    Published in Swissreg on 11.10.2022

  5. Apr 16, 2014

    Agent’s address changed

    Representative
    A. W. Metz & Co. AG, Hottingerstrasse 14, 8024 Zürich → A.W. Metz & Co. AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 16.04.2014

  6. Jun 10, 2013

    Registered

    Published in Swissreg on 10.06.2013

Parties

Holder

Allergan, Inc.

2525 Dupont Drive, Irvine, CA 92612, US

Allergan, Inc.

2525 Dupont Drive, Irvine (CA 92715), US

Agent

Baker McKenzie Switzerland AG

Holbeinstrasse 30, 8034 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.